Seiji Kawa
Partner, PwC Advisory LLC
Specialty
Pharmaceuticals and life sciences, healthcare, private equity
company-wide growth strategy, new business strategy, M&A strategy, business due diligence, post-merger integration (PMI), commercial model transformation, R&D strategy
Summary of expertise
Before taking up his current position, Seiji Kawa was engaged in life science research at academic institutes in both Japan and the US, and worked for several foreign-affiliated consulting firms.
Seijispecialises in the healthcare sector with a particular focus on transformation based on mid-to long-term growth strategies, as well as support for new businesses and M&A.
In addition to providing support to the traditional businesses of pharmaceutical and medical device companies, Seiji has recently been concentrating on supporting new initiatives in the area of healthcare that aim to realise an ideal healthcare ecosystem. These initiatives include market entry by companies in other industries and the start-up of new collaborative businesses by healthcare companies, peripheral industries and investment funds.
